Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Marth

Showing results (121-130 of 237) with videos related to

Pageof 24
Sort By:
Wiener Klinische Wochenschrift|March 20, 2019
Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and GynecologyVesna Bjelic-Radisic, Christian Singer, Karl Tamussino, et al.
Gynecologic Oncology|May 9, 2006
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancerGilbert Spizzo, Philip Went, Stephan Dirnhofer, et al.
Wiener Klinische Wochenschrift|June 26, 2015
AGO Austria recommendations for genetic testing of patients with ovarian cancerChristian Marth, Michael Hubalek, Edgar Petru, et al.
International Journal of Cancer|January 27, 2009
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancerAlain G Zeimet, Daniel Reimer, Dominik Wolf, et al.
The Journal of Sexual Medicine|January 11, 2020
Perception of Labial Size and Objective Measurements-Is There a Correlation? A Cross-Sectional Study in a Cohort Not Seeking LabiaplastyAndreas Widschwendter, David Riedl, Katharina Freidhager, et al.
Journal of Cancer|February 13, 2020
The miR-34 family and its clinical significance in ovarian cancerHannah Welponer, Irina Tsibulak, Verena Wieser, et al.
Clinical Epigenetics|November 28, 2024
BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancerHeidelinde Fiegl, Simon Schnaiter, Daniel U Reimer, et al.
Cancer Research|November 13, 2003
Calgranulins in cystic fluid and serum from patients with ovarian carcinomasHelmut W Ott, Herbert Lindner, Bettina Sarg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusionsMichael Fiegl, Margot Haun, Anita Massoner, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2010
Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancerAlain G Zeimet, Daniel Reimer, Lukas Schwentner, et al.
Pageof 24

Showing results (121-130 of 237) with videos related to

Sort By:
Pageof 24
Wiener Klinische Wochenschrift|March 20, 2019
Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and GynecologyVesna Bjelic-Radisic, Christian Singer, Karl Tamussino, et al.
Gynecologic Oncology|May 9, 2006
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancerGilbert Spizzo, Philip Went, Stephan Dirnhofer, et al.
Wiener Klinische Wochenschrift|June 26, 2015
AGO Austria recommendations for genetic testing of patients with ovarian cancerChristian Marth, Michael Hubalek, Edgar Petru, et al.
International Journal of Cancer|January 27, 2009
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancerAlain G Zeimet, Daniel Reimer, Dominik Wolf, et al.
The Journal of Sexual Medicine|January 11, 2020
Perception of Labial Size and Objective Measurements-Is There a Correlation? A Cross-Sectional Study in a Cohort Not Seeking LabiaplastyAndreas Widschwendter, David Riedl, Katharina Freidhager, et al.
Journal of Cancer|February 13, 2020
The miR-34 family and its clinical significance in ovarian cancerHannah Welponer, Irina Tsibulak, Verena Wieser, et al.
Clinical Epigenetics|November 28, 2024
BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancerHeidelinde Fiegl, Simon Schnaiter, Daniel U Reimer, et al.
Cancer Research|November 13, 2003
Calgranulins in cystic fluid and serum from patients with ovarian carcinomasHelmut W Ott, Herbert Lindner, Bettina Sarg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusionsMichael Fiegl, Margot Haun, Anita Massoner, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2010
Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancerAlain G Zeimet, Daniel Reimer, Lukas Schwentner, et al.
Pageof 24